FMBH
First Mid Bancshares, Inc.
FMBH's outlook is improving, though it still trails on the overall score.
MS
Morgan Stanley
MS has the edge over FMBH overall, supported by stronger modeled upside and stronger valuation.
FMBH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
FMBH's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FMBH.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
FMBH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.2x | $39.79 | -22% |
| Fair | 11x | $46.53 | -9.1% |
| Forward | 11x | $51.19 | — |
| Current | 12x | $51.19 | — |
| Expensive | 13x | $56.93 | +11% |
Historical ranges are pointers, not guarantees.
FMBH has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
FMBH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for FMBH, with profitability holding steady.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over FMBH on the outlook, with more favorable profitability expectations.
FMBH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.75 | +9.6% |
| Q3 2026 | $4.33 | +18% |
| Q2 2026 | $4.02 | +14% |
| Q1 2026 | $3.96 | +18% |
| Q4 2025 | $3.83 | +16% |
| Q3 2025 | $3.66 | +13% |
| Q2 2025 | $3.53 | +14% |
| Q1 2025 | $3.37 | +9.4% |
| Q4 2024 | $3.30 | +4.8% |
FMBH's earnings per share have climbed steadily: $4.33 over the past year, up 18% from the year before, and higher year over year for eight quarters in a row.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over FMBH on earnings, with stronger typical year-over-year growth.
FMBH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $106.6M | +19% |
| Q2 2026 | $108.5M | +24% |
| Q1 2026 | $97.2M | +15% |
| Q4 2025 | $88.2M | +3.4% |
| Q3 2025 | $89.3M | +11% |
| Q2 2025 | $87.5M | +10% |
| Q1 2025 | $84.3M | +5.4% |
| Q4 2024 | $85.3M | +7.7% |
FMBH's revenue has grown year over year for 13 quarters in a row: $107M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 39% | +7.1 points |
| Q2 2026 | 33% | -1 points |
| Q1 2026 | 35% | +1.5 points |
| Q4 2025 | 34% | +4.3 points |
| Q3 2025 | 32% | +0.7 points |
| Q2 2025 | 34% | +0.7 points |
| Q1 2025 | 33% | -0.3 points |
| Q4 2024 | 30% | +2.4 points |
FMBH has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over FMBH on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
FMBH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $45.8M | +43% |
| Q2 2026 | $24.2M | +305% |
| Q1 2026 | $23.1M | -50% |
| Q4 2025 | $40.2M | +8.5% |
| Q3 2025 | $31.9M | -0.3% |
| Q2 2025 | $6M | -74% |
| Q1 2025 | $46M | +67% |
| Q4 2024 | $37M | +31% |
FMBH has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
FMBH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -3K shares |
| 1 year | +11% | +2.6M shares |
| 3 years | +19% | +4.3M shares |
| 5 years | +47% | +8.5M shares |
| Available history | +59% | +9.9M shares |
FMBH has 27M diluted shares, up 11% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $921,000 |
| Q1 2026 | $500,000 |
| Q4 2024 | $659,000 |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | $460,000 |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over FMBH on shareholder dilution, with a more favorable share count trend.
FMBH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2020 | -0.8x | Net Cash |
| Q4 2019 | -1.2x | Net Cash |
FMBH has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FMBH.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
FMBH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.6 | Neutral |
| Stochastic | 53.0 | Neutral |
FMBH's weekly RSI is 62 (neutral) and its Stochastic is 53 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
FMBH PE vs Financial Services Sector
| Metric | FMBH | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 9.2% below |
| PE % | 66 | 63 | 3 pts above |
FMBH has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
FMBH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $50.1 | 2.2% above |
| 20 week MA | $50.3 | 1.8% above |
| 50 week MA | $45.6 | 12% above |
| 100 week MA | $41.2 | 24% above |
| 200 week MA | $36.5 | 40% above |
FMBH has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
FMBH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.3 | $33.5 | -5.1% |
| 2021 | $33.5 | $42.6 | +27% |
| 2022 | $42.6 | $32.2 | -24% |
| 2023 | $32.2 | $34.7 | +7.7% |
| 2024 | $34.7 | $37.0 | +6.7% |
| 2025 | $37.0 | $40.0 | +8.1% |
| 2026 YTD | $40.0 | $51.2 | +28% |
FMBH has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.